Hat mitgewirkt an:
-
Die Wirkung von epigenetischen Medikamenten in einem Xenotransplantationsmodell der juvenilen myelomonozytären Leukämie
-
CREBBP is a target of epigenetic, but not genetic, modification in juvenile myelomonocytic leukemia
-
Transient apoptosis inhibition in donor stem cells improves hematopoietic stem cell transplantation
-
CREBBP is a target of epigenetic, but not genetic, modification in juvenile myelomonocytic leukemia